-
Je něco špatně v tomto záznamu ?
Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy
J. Naar, I. Skalský, A. Krűger, F. Málek, K. Van Bladel, LS. Annest, P. Moučka, T. Mráz, VY. Reddy, P. Neužil
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- dysfunkce levé srdeční komory diagnostické zobrazování chirurgie MeSH
- ischemická choroba srdeční diagnostické zobrazování chirurgie MeSH
- kardiochirurgické výkony metody MeSH
- kardiomyopatie diagnostické zobrazování chirurgie MeSH
- lidé středního věku MeSH
- lidé MeSH
- prospektivní studie MeSH
- tepový objem MeSH
- test chůzí MeSH
- zákroky plastické chirurgie metody MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The evidence supporting surgical aneurysmectomy in ischemic heart failure is inconsistent. The aim of the study was to describe long-term effect of minimally invasive hybrid transcatheter and minithoracotomy left ventricular (LV) reconstruction in patients with ischemic cardiomyopathy. Twenty-three subjects with transmural anterior wall scarring, LV ejection fraction 15-45%, and New York Heart Association class ≥ II were intervened using Revivent TC anchoring system. LV end-systolic volume index was reduced from 73.2 ± 27 ml at baseline to 51.5 ± 22 ml after 6 months (p < 0.001), 49.9 ± 20 ml after 2 years (p < 0.001), and 56.1 ± 16 ml after 5 years (p = 0.047). NYHA class improved significantly at 5 years compared to baseline. Six-min walk test distance increased at 2 years compared to the 6-month visit. Hybrid LV reconstruction using the anchoring system provides significant and durable LV volume reduction during 5-year follow-up in preselected patients with ischemic heart failure. Legend: Hybrid left ventricular reconstruction using the anchoring system provides significant and durable LV volume reduction throughout 5-year follow-up in preselected patients with ischemic heart failure.
BioVentrix Inc San Ramon CA USA
Cardiac Arrhythmia Service Mount Sinai Medical Center New York USA
Department of Cardiac Surgery Na Homolce Hospital Prague Czech Republic
Department of Cardiology Na Homolce Hospital Röentgenova 37 2 150 30 Prague 5 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011825
- 003
- CZ-PrNML
- 005
- 20220506131145.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12265-021-10133-9 $2 doi
- 035 __
- $a (PubMed)33974231
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Naar, Jan $u Department of Cardiology, Na Homolce Hospital, Röentgenova 37/2, 150 30, Prague 5, Czech Republic. jan.naar@seznam.cz $1 https://orcid.org/0000000276307039
- 245 10
- $a Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy / $c J. Naar, I. Skalský, A. Krűger, F. Málek, K. Van Bladel, LS. Annest, P. Moučka, T. Mráz, VY. Reddy, P. Neužil
- 520 9_
- $a The evidence supporting surgical aneurysmectomy in ischemic heart failure is inconsistent. The aim of the study was to describe long-term effect of minimally invasive hybrid transcatheter and minithoracotomy left ventricular (LV) reconstruction in patients with ischemic cardiomyopathy. Twenty-three subjects with transmural anterior wall scarring, LV ejection fraction 15-45%, and New York Heart Association class ≥ II were intervened using Revivent TC anchoring system. LV end-systolic volume index was reduced from 73.2 ± 27 ml at baseline to 51.5 ± 22 ml after 6 months (p < 0.001), 49.9 ± 20 ml after 2 years (p < 0.001), and 56.1 ± 16 ml after 5 years (p = 0.047). NYHA class improved significantly at 5 years compared to baseline. Six-min walk test distance increased at 2 years compared to the 6-month visit. Hybrid LV reconstruction using the anchoring system provides significant and durable LV volume reduction during 5-year follow-up in preselected patients with ischemic heart failure. Legend: Hybrid left ventricular reconstruction using the anchoring system provides significant and durable LV volume reduction throughout 5-year follow-up in preselected patients with ischemic heart failure.
- 650 _2
- $a kardiochirurgické výkony $x metody $7 D006348
- 650 _2
- $a kardiomyopatie $x diagnostické zobrazování $x chirurgie $7 D009202
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a ischemická choroba srdeční $x diagnostické zobrazování $x chirurgie $7 D017202
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a zákroky plastické chirurgie $x metody $7 D019651
- 650 _2
- $a tepový objem $7 D013318
- 650 _2
- $a dysfunkce levé srdeční komory $x diagnostické zobrazování $x chirurgie $7 D018487
- 650 _2
- $a test chůzí $7 D000070857
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Skalský, Ivo $u Department of Cardiac Surgery, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Krűger, Andreas $u Department of Cardiology, Na Homolce Hospital, Röentgenova 37/2, 150 30, Prague 5, Czech Republic
- 700 1_
- $a Málek, Filip $u Department of Cardiology, Na Homolce Hospital, Röentgenova 37/2, 150 30, Prague 5, Czech Republic
- 700 1_
- $a Van Bladel, Kevin $u BioVentrix, Inc., San Ramon, CA, USA
- 700 1_
- $a Annest, Lon S $u BioVentrix, Inc., San Ramon, CA, USA
- 700 1_
- $a Moučka, Petr $u Department of Cardiology, Na Homolce Hospital, Röentgenova 37/2, 150 30, Prague 5, Czech Republic
- 700 1_
- $a Mráz, Tomáš $u Department of Cardiology, Na Homolce Hospital, Röentgenova 37/2, 150 30, Prague 5, Czech Republic
- 700 1_
- $a Reddy, Vivek Y $u Cardiac Arrhythmia Service, Mount Sinai Medical Center, New York, USA
- 700 1_
- $a Neužil, Petr $u Department of Cardiology, Na Homolce Hospital, Röentgenova 37/2, 150 30, Prague 5, Czech Republic
- 773 0_
- $w MED00184059 $t Journal of cardiovascular translational research $x 1937-5395 $g Roč. 14, č. 6 (2021), s. 1043-1050
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33974231 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131137 $b ABA008
- 999 __
- $a ok $b bmc $g 1789433 $s 1163026
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 14 $c 6 $d 1043-1050 $e 20210511 $i 1937-5395 $m Journal of cardiovascular translational research $n J Cardiovasc Transl Res $x MED00184059
- LZP __
- $a Pubmed-20220425